Tradestie Institutional Equity Comparison Engine
MGRX vs CISS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CISS Overall Edge
CISS Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C3is Inc. Common Stock (CISS) driven by superior Growth & Margin, Momentum & Technical while MGRX counters with relative strength in Options & Structure. Fundamentally, MGRX trades at N/M Forward P/E with -4173.6% operating margin (-59.1% YoY revenue) versus CISS at N/M Forward P/E and 24.6% operating margin (+249.0% YoY). In options structure, MGRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CISS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MGRX N/M vs CISS N/M Fwd P/E
Growth & Margin Winner
CISS
Op Margin -4173.6% vs 24.6% ยท YoY -59.1% vs +249.0%
Momentum & Technical Winner
CISS
1Y -90.0% vs -25.4% ยท 52W Pos 0% vs 20%
Options & Structure Winner
MGRX
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
MGRX
NASDAQ
Mangoceuticals, Inc. Common Stock
Services-Misc Health & Allied Services, Nec
$0.12
-7.55% 1D
Market Cap
$3.0M
1M Return
-49.41%
1Y Return
-90.03%
Forward P/E
N/M
Unified AI Score
40.5 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 59.0
CISS
NASDAQ
C3is Inc. Common Stock
Deep Sea Foreign Transportation Of Freight
$1.23
+4.24% 1D
Market Cap
$991,199
1M Return
+135.23%
1Y Return
-25.45%
Forward P/E
N/M
Unified AI Score
33.6 / 100
SELL
Tech 5.0
Fund 29.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MGRX -90.03%
CISS -25.45%
Spread: +64.58 pp (CISS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MGRX Revenue | CISS Revenue | MGRX Op. Margin | CISS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | $0M | N/A | -22279.7% | N/A | MGRX |
| FY2023 | $0M | $30M | -1260.3% | 36.3% | CISS |
| FY2024 | $0M | $40M | -1294.4% | 23.8% | CISS |
| FY2025 | $0M | $30M | -3954.3% | 3.9% | CISS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MGRX | CISS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.0M | $991,199 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -59.1% | +249.0% | Higher Growth | CISS |
| Operating Margin (TTM) Profitability | -4173.6% | 24.6% | Higher Margin | CISS |
| Net Profit Margin Profitability | 0.0% | 27.4% | Higher Margin | CISS |
| Return on Equity (ROE) Capital Efficiency | -95.1% | 17.1% | Higher ROE | CISS |
| 52-Week Range Position Momentum | 0% ($0โ$1) | 20% ($0โ$6) | Stronger Trend | CISS |
| Beta / 30D Volatility Risk Regime | 1.53ฮฒ ยท 87% Vol | 11.91ฮฒ ยท 1054% Vol | Lower Realized Risk | MGRX |
| Unified Institutional Score Composite Signal | 40.5 / 100 (SELL) | 33.6 / 100 (SELL) | Higher Composite | MGRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MGRX vs CISS Buy Guide
MGRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CISS
BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MGRX nor CISS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.